Sign in

NCT07313306Recruiting

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise

Source: ClinicalTrials.gov · Last updated 20 Jan 2026

Brief summary (registry, in English)

This study will examine unmet exercise needs among patients with metastatic breast cancer (MBC) at UNC and assess whether participation in Get Real and Heel (GRH) can increase physical activity. The proposed research aims to improve multiple domains of well-being, quality of life, physical function, social support and reduce social isolation through a community based exercise intervention. By leveraging underutilized University of North Carolina Chapel Hill (UNC) resources, this work seeks to reduce barriers to accessibility, awareness, and appropriateness of exercise programming for this underserved population. Findings will help close the gap between patients' exercise needs, interest, and participation, with potential benefits for symptoms, functioning, and quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
17 Dec 2025
Start date
15 Dec 2025
Primary completion date
1 Jul 2028
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
NCT number
NCT07313306

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 15 Dec 2025 to the primary completion date, 1 Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently on hospice.

Other

  • Bed-bound status or other contraindication to exercise
  • Participation in GRH since their diagnosis with MBC

Who the study is looking for

  • Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
  • Subjects are willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
  • Age \> 18 years at the time of consent.
  • Diagnosis of metastatic breast cancer within two years of consent date
  • Receives medical clearance from clinical team for moderate intensity exercise programming
  • Indicates intent to receive ongoing cancer care at the enrolling institution
  • English Speaking - program and measures are in English and not practicably translatable for a study this size.

Criteria the registry did not label

  • In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.